Prudential Financial Inc. lowered its stake in Gentherm Incorporated (NASDAQ:THRM – Free Report) by 9.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and ...

Can AI find winning penny stock investments? Zaven Boyrazian puts ChatGPT to the test and discovers a potentially interesting ...

The Oracle of Omaha's all-time favorite stock to purchase has outpaced the S&P 500 by more than 21 percentage points in 2025, ...

The Australian sharemarket sank on the opening bell, wiping $50bn to $60bn off the market, after US President Donald Trump ...

The S&P 500 popped on the final day of March to end a rough quarter on an upbeat note. The benchmark still fell 6% in Q1, ...

Small-cap penny stock: Shares of business and IT solutions provider Bartronics India jumped 8 per cent after the company announced overseas business expansion. Trent share price has skyrocketed an ...

European markets have recently faced challenges, with the pan-European STOXX Europe 600 Index ending about 1.4% lower due to new U.S. trade tariffs, despite earlier optimism from positive economic ...

Are penny shares the best thing since sliced bread, or are they evil things to be shunned? The truth lies between the ...

Canadian and American markets tumbled Friday amid inflation worries and uncertainty over the scale and scope of the next ...

As the Australian market experiences a mix of sector performances, with energy leading gains and real estate facing declines, ...

The Australian market, which had been experiencing a promising start to the week, is now feeling the ripple effects of renewed tariff tensions from the U.S., impacting global indices and sparking ...

Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ongoing business development plans.